Home
About
FAQ
History (2)
Advances in and hope for the treatment of parasitosis.
High viral burden restricts short-lived effector cell number at late times postinfection through increased natural regulatory T cell expansion.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Advances in and hope for the treatment of parasitosis.
Feldman SR. Advances in and hope for the treatment of parasitosis. J Dermatolog Treat. 2016; 27(3):197.
View in:
PubMed
authors with profiles
Steven R. Feldman MD, PhD